Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-018173-31Phase 3Completed
Phase 3, randomised, double-blind trial of aspirin and clonidine (4 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoint: Primary composite cardiovascular event rate at 30 days. Started Jan 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-018173-31.